董事介绍
注：董事持股数取自最新公司公告
| 姓名 | 性别 | 职位 | 年龄 | 薪酬 | 持股数(万股) | 截止日期 |
|---|---|---|---|---|---|---|
| Zane Burke | 男 | Director, Chief Executive Officer | 54 | 1003.86万美元 | 未持股 | 2020-03-31 |
| Christopher Bischoff | 男 | Independent Director | 46 | 未披露 | 未持股 | 2020-03-31 |
| Sandra Fenwick | 女 | Independent Director | 69 | 105.83万美元 | 未持股 | 2020-03-31 |
| Hemant Taneja | 男 | Independent Director | 45 | 未披露 | 未持股 | 2020-03-31 |
| Philip D. Green | 男 | Lead Independent Director | 69 | 130.35万美元 | 未持股 | 2020-03-31 |
| Glen E. Tullman | 男 | Executive Chairman and Director | 60 | 62.81万美元 | 未持股 | 2020-03-31 |
| Karen L. Daniel | 女 | Independent Director | 62 | 138.53万美元 | 未持股 | 2020-03-31 |
高管介绍
注：高管持股数取自最新公司公告
| 姓名 | 性别 | 职位 | 年龄 | 薪酬 | 持股数(万股) | 截止日期 |
|---|---|---|---|---|---|---|
| Lee Shapiro | 男 | Chief Financial Officer | 64 | 1307.14万美元 | 未持股 | 2020-03-31 |
| Jennifer Schneider | 女 | President | 45 | 未披露 | 未持股 | 2020-03-31 |
| Zane Burke | 男 | Director, Chief Executive Officer | 54 | 1003.86万美元 | 未持股 | 2020-03-31 |
| James Pursley | 男 | Chief Commercial Officer | 40 | 74.41万美元 | 未持股 | 2020-03-31 |
| Jennifer Schneider | 女 | President | 45 | 270.66万美元 | 未持股 | 2020-03-31 |
| Glen E. Tullman | 男 | Executive Chairman and Director | 60 | 62.81万美元 | 未持股 | 2020-03-31 |
董事简历
中英对照 | 中文 | 英文- Zane Burke
-
Zane Burke自2019年2月起担任我们的首席执行官，自2019年4月起担任我们的董事之一。在加入我们之前，他曾在塞纳公司担任多个执行职位，该公司是一家健康信息技术解决方案、服务、设备和硬件提供商，1996年9月至2018年11月，最近担任总裁（2013年9月至2018年11月）和执行Vice President-客户组织（2011年7月至2013年9月）。Burke先生拥有堪萨斯州立大学（Kansas State University）会计学学士学位和会计学硕士学位。他是一名注册会计师，但不再持有有效执照。此外，伯克先生还担任杜鲁门医学中心、梦百合信息管理执行学院和堪萨斯州立大学商学院咨询委员会的董事。
Zane Burke has served as our Chief Executive Officer since February 2019 and as one of our directors since April 2019. Prior to joining us, he served in various executive roles at Cerner Corporation, a provider of health information technology solutions, services, devices and hardware, from September 1996 to November 2018 most recently as President from September 2013 until November 2018 and Executive Vice President - Client Organization from July 2011 to September 2013. Mr. Burke holds a B.S. in Accounting and a Masters of Accountancy from Kansas State University. He is a certified public accountant, but no longer keeps an active license. Additionally, Mr. Burke serves on the Board of the Truman Medical Center, the Board of the College of Healthcare Information Management Executives and the Kansas State University School of Business Advisory Council. - Zane Burke自2019年2月起担任我们的首席执行官，自2019年4月起担任我们的董事之一。在加入我们之前，他曾在塞纳公司担任多个执行职位，该公司是一家健康信息技术解决方案、服务、设备和硬件提供商，1996年9月至2018年11月，最近担任总裁（2013年9月至2018年11月）和执行Vice President-客户组织（2011年7月至2013年9月）。Burke先生拥有堪萨斯州立大学（Kansas State University）会计学学士学位和会计学硕士学位。他是一名注册会计师，但不再持有有效执照。此外，伯克先生还担任杜鲁门医学中心、梦百合信息管理执行学院和堪萨斯州立大学商学院咨询委员会的董事。
- Zane Burke has served as our Chief Executive Officer since February 2019 and as one of our directors since April 2019. Prior to joining us, he served in various executive roles at Cerner Corporation, a provider of health information technology solutions, services, devices and hardware, from September 1996 to November 2018 most recently as President from September 2013 until November 2018 and Executive Vice President - Client Organization from July 2011 to September 2013. Mr. Burke holds a B.S. in Accounting and a Masters of Accountancy from Kansas State University. He is a certified public accountant, but no longer keeps an active license. Additionally, Mr. Burke serves on the Board of the Truman Medical Center, the Board of the College of Healthcare Information Management Executives and the Kansas State University School of Business Advisory Council.
- Christopher Bischoff
-
Christopher Bischoff自2018年4月起担任我们的董事之一。2013年10月起，他担任瑞典投资公司Kinnevik AB的高级投资总监。Bischoff从2001年4月到2013年9月担任Goldman Sachs（一家投资银行和金融服务公司）董事总经理以及欧洲媒体和互联网主管。他目前担任几家私人控股公司的董事会成员。Bischoff先生拥有布里斯托尔大学（University of Bristol）历史学学士学位和欧洲工商管理学院（INSEAD）工商管理硕士学位。
Christopher Bischoff has served as one of our directors since April 2018. He has served as Senior Investment Director at Kinnevik AB, a Swedish investment company, since October 2013. Mr. Bischoff previously served as a Managing Director and Head of European Media and Internet at Goldman Sachs, an investment bank and financial services company, from April 2001 to September 2013. He currently serves as a member of the board of directors of several privately-held companies. Mr. Bischoff holds a B.A. in History from the University of Bristol and an M.B.A. from INSEAD. - Christopher Bischoff自2018年4月起担任我们的董事之一。2013年10月起，他担任瑞典投资公司Kinnevik AB的高级投资总监。Bischoff从2001年4月到2013年9月担任Goldman Sachs（一家投资银行和金融服务公司）董事总经理以及欧洲媒体和互联网主管。他目前担任几家私人控股公司的董事会成员。Bischoff先生拥有布里斯托尔大学（University of Bristol）历史学学士学位和欧洲工商管理学院（INSEAD）工商管理硕士学位。
- Christopher Bischoff has served as one of our directors since April 2018. He has served as Senior Investment Director at Kinnevik AB, a Swedish investment company, since October 2013. Mr. Bischoff previously served as a Managing Director and Head of European Media and Internet at Goldman Sachs, an investment bank and financial services company, from April 2001 to September 2013. He currently serves as a member of the board of directors of several privately-held companies. Mr. Bischoff holds a B.A. in History from the University of Bristol and an M.B.A. from INSEAD.
- Sandra Fenwick
-
Sandra Fenwick自2019年4月起担任我们的董事之一。Fenwick女士从2013年开始担任波士顿儿童医院（Boston Children&8217；s Hospital）的首席执行官。她此前曾担任Boston Children&8217；s Hospital的首席运营官兼总裁。Fenwick女士目前任职于几家私人控股公司的董事会，包括哈佛大学怀斯生物启发工程研究所，Children’；s Hospital Association，Inc.，CRICO，Ltd.。开曼群岛，Crico Vermont，Inc.和马萨诸塞州数字健康委员会。Fenwick女士拥有西蒙斯学院（Simmons College）的生物学和化学学士学位，以及得克萨斯大学公共卫生学院（University of Texas School of Public Health）的卫生服务管理和流行病学硕士学位。
Sandra Fenwick has served as one of our directors since April 2019. Ms. Fenwick has served as the Chief Executive Officer of Boston Children’s Hospital since 2013. She previously served as the Chief Operating Officer and President of Boston Children’s Hospital. Ms. Fenwick currently serves on the boards of directors of several privately-held companies, including the Wyss Institute for Biologically Inspired Engineering at Harvard University, Inc., Children’s Hospital Association, Inc., CRICO, Ltd. Cayman, CRICO Vermont, Inc. and Massachusetts Digital Health Council. Ms. Fenwick holds a B.S. in Biology and Chemistry from Simmons College and an M.P.H. in Health Services Administration and Epidemiology from the University of Texas School of Public Health. - Sandra Fenwick自2019年4月起担任我们的董事之一。Fenwick女士从2013年开始担任波士顿儿童医院（Boston Children&8217；s Hospital）的首席执行官。她此前曾担任Boston Children&8217；s Hospital的首席运营官兼总裁。Fenwick女士目前任职于几家私人控股公司的董事会，包括哈佛大学怀斯生物启发工程研究所，Children’；s Hospital Association，Inc.，CRICO，Ltd.。开曼群岛，Crico Vermont，Inc.和马萨诸塞州数字健康委员会。Fenwick女士拥有西蒙斯学院（Simmons College）的生物学和化学学士学位，以及得克萨斯大学公共卫生学院（University of Texas School of Public Health）的卫生服务管理和流行病学硕士学位。
- Sandra Fenwick has served as one of our directors since April 2019. Ms. Fenwick has served as the Chief Executive Officer of Boston Children’s Hospital since 2013. She previously served as the Chief Operating Officer and President of Boston Children’s Hospital. Ms. Fenwick currently serves on the boards of directors of several privately-held companies, including the Wyss Institute for Biologically Inspired Engineering at Harvard University, Inc., Children’s Hospital Association, Inc., CRICO, Ltd. Cayman, CRICO Vermont, Inc. and Massachusetts Digital Health Council. Ms. Fenwick holds a B.S. in Biology and Chemistry from Simmons College and an M.P.H. in Health Services Administration and Epidemiology from the University of Texas School of Public Health.
- Hemant Taneja
-
Hemant Taneja自2014年4月以来一直担任我们的董事之一。他自2007年9月以来担任General Catalyst（一家风险投资公司）的董事总经理。Taneja先生在几家私人控股公司的董事会任职。Taneja先生毕业于麻省理工学院（Massachusetts Institute of Technology），获得运筹学硕士学位和硕士学位。电气工程与计算机科学学士学位，数学学士学位，电气工程与计算机科学学士学位，生物学与生物医学工程学士学位。
Hemant Taneja,has served as a member of Samsara Inc. Board of Directors since June 2017. He has served as the Chief Executive Officer of General Catalyst, a venture capital firm, since 2021 and previously as a Managing Director since September 2007. Mr. Taneja previously served as the Chief Executive Officer and Chairman of the board of directors of Health Assurance Acquisition Corp., a special purpose acquisition company focused on the healthcare industry, from September 2020 to November 2022. Mr. Taneja also serves on the board of directors of several private companies. Mr. Taneja previously served on the board of directors of Teladoc Health, Inc., a telemedicine and virtual healthcare company, from November 2020 to April 2021. Mr. Taneja holds a M.S. in Operations Research, a M.Eng. in Electrical Engineering and Computer Science, a B.S. in Mathematics, a B.S. in Electrical Engineering and Computer Science, and a B.S. in Biology and Biomedical Engineering from the Massachusetts Institute of Technology. - Hemant Taneja自2014年4月以来一直担任我们的董事之一。他自2007年9月以来担任General Catalyst（一家风险投资公司）的董事总经理。Taneja先生在几家私人控股公司的董事会任职。Taneja先生毕业于麻省理工学院（Massachusetts Institute of Technology），获得运筹学硕士学位和硕士学位。电气工程与计算机科学学士学位，数学学士学位，电气工程与计算机科学学士学位，生物学与生物医学工程学士学位。
- Hemant Taneja,has served as a member of Samsara Inc. Board of Directors since June 2017. He has served as the Chief Executive Officer of General Catalyst, a venture capital firm, since 2021 and previously as a Managing Director since September 2007. Mr. Taneja previously served as the Chief Executive Officer and Chairman of the board of directors of Health Assurance Acquisition Corp., a special purpose acquisition company focused on the healthcare industry, from September 2020 to November 2022. Mr. Taneja also serves on the board of directors of several private companies. Mr. Taneja previously served on the board of directors of Teladoc Health, Inc., a telemedicine and virtual healthcare company, from November 2020 to April 2021. Mr. Taneja holds a M.S. in Operations Research, a M.Eng. in Electrical Engineering and Computer Science, a B.S. in Mathematics, a B.S. in Electrical Engineering and Computer Science, and a B.S. in Biology and Biomedical Engineering from the Massachusetts Institute of Technology.
- Philip D. Green
-
Philip D. Green，他于1992年当选我们的董事。他是PDG Consulting公司（医疗保健IT咨询公司）的总裁。从2006年7月到2008年11月30日，他曾担任美国匹兹堡大学医学中心（University of Pittsburgh Medical Center,UPMC）的负责战略业务计划的总裁。加入UPMC之前，他曾担任Gardner Carton & Douglas公司的律师事务所的合伙人（2004年6月以来）。从2000年6月到2004年6月，他曾担任Akin, Gump, Strauss, Hauer & Feld公司的合伙人。从1989年到2000年6月，他曾担任Green, Stewart, Farber & Anderson公司（他是该公司的创始合伙人）的律师事务所的合伙人。从1978年到1989年，他曾担任Schwalb, Donnenfeld, Bray & Silbert公司的华盛顿特区的律师事务所的合伙人。
Philip D. Green has served as one of our directors since September 2016. He has served as President of PDG Consulting, LLC, a healthcare IT consulting company since November 2008. From July 2006 to November 2008 Mr. Green served as President, Strategic Business Initiatives, at the University of Pittsburgh Medical Center. He previously served as a partner at the law firms of Gardner Carton & Douglas, LLP, Akin, Gump, Strauss, Hauer & Feld, L.L.P., and Schwalb, Donnenfeld, Bray & Silbert, P.C., a founding principal at Green, Stewart, Farber & Anderson, P.C., and of counsel at Drinker Biddle & Reath, LLP. Mr. Green holds a B.S. in Urban Studies from the University of Pennsylvania and a J.D. from the George Washington University Law School. - Philip D. Green，他于1992年当选我们的董事。他是PDG Consulting公司（医疗保健IT咨询公司）的总裁。从2006年7月到2008年11月30日，他曾担任美国匹兹堡大学医学中心（University of Pittsburgh Medical Center,UPMC）的负责战略业务计划的总裁。加入UPMC之前，他曾担任Gardner Carton & Douglas公司的律师事务所的合伙人（2004年6月以来）。从2000年6月到2004年6月，他曾担任Akin, Gump, Strauss, Hauer & Feld公司的合伙人。从1989年到2000年6月，他曾担任Green, Stewart, Farber & Anderson公司（他是该公司的创始合伙人）的律师事务所的合伙人。从1978年到1989年，他曾担任Schwalb, Donnenfeld, Bray & Silbert公司的华盛顿特区的律师事务所的合伙人。
- Philip D. Green has served as one of our directors since September 2016. He has served as President of PDG Consulting, LLC, a healthcare IT consulting company since November 2008. From July 2006 to November 2008 Mr. Green served as President, Strategic Business Initiatives, at the University of Pittsburgh Medical Center. He previously served as a partner at the law firms of Gardner Carton & Douglas, LLP, Akin, Gump, Strauss, Hauer & Feld, L.L.P., and Schwalb, Donnenfeld, Bray & Silbert, P.C., a founding principal at Green, Stewart, Farber & Anderson, P.C., and of counsel at Drinker Biddle & Reath, LLP. Mr. Green holds a B.S. in Urban Studies from the University of Pennsylvania and a J.D. from the George Washington University Law School.
- Glen E. Tullman
-
Glen E. Tullman，1997年8月加入，担任首席执行官，领导本公司进入医疗保健信息行业。1999年5月，他当选为本公司董事。加入Allscripts之前，1994年10月至1997年7月，他担任Enterprise Systems的首席执行官，这是一个医疗信息服务公司，为大型综合医疗保健网络提供资源管理解决方案。1983-1994，他在CCC Information Services担任过一些管理职务，其中包括总裁、首席运营官，这是财产与意外保险公司的信息系统提供商。他目前任职于Juvenile Diabetes Research Foundation的国际委员会。
Glen E. Tullman is a founder of the Company and has served as our Executive Chairman since February 2019 and previously served as our Chief Executive Officer from September 2014 to February 2019. Mr. Tullman has also served as one of our directors since August 2013. He co-founded 7Wire Ventures, an early-stage healthcare venture fund, and has served as a Managing Partner since January 2013. Previously, Mr. Tullman served as Chief Executive Officer and as a director of Allscripts Healthcare Solutions, Inc., a provider of electronic prescribing, practice management and electronic health record technology, from August 1997 to December 2012. He serves as a Director Emeritus to the International Board of the Juvenile Diabetes Research Foundation and on the board of directors of the American Diabetes Association. Mr. Tullman holds a B.A. in Economics from Bucknell University and an advanced degree in Social Anthropology from St. Antony’s College, University of Oxford. - Glen E. Tullman，1997年8月加入，担任首席执行官，领导本公司进入医疗保健信息行业。1999年5月，他当选为本公司董事。加入Allscripts之前，1994年10月至1997年7月，他担任Enterprise Systems的首席执行官，这是一个医疗信息服务公司，为大型综合医疗保健网络提供资源管理解决方案。1983-1994，他在CCC Information Services担任过一些管理职务，其中包括总裁、首席运营官，这是财产与意外保险公司的信息系统提供商。他目前任职于Juvenile Diabetes Research Foundation的国际委员会。
- Glen E. Tullman is a founder of the Company and has served as our Executive Chairman since February 2019 and previously served as our Chief Executive Officer from September 2014 to February 2019. Mr. Tullman has also served as one of our directors since August 2013. He co-founded 7Wire Ventures, an early-stage healthcare venture fund, and has served as a Managing Partner since January 2013. Previously, Mr. Tullman served as Chief Executive Officer and as a director of Allscripts Healthcare Solutions, Inc., a provider of electronic prescribing, practice management and electronic health record technology, from August 1997 to December 2012. He serves as a Director Emeritus to the International Board of the Juvenile Diabetes Research Foundation and on the board of directors of the American Diabetes Association. Mr. Tullman holds a B.A. in Economics from Bucknell University and an advanced degree in Social Anthropology from St. Antony’s College, University of Oxford.
- Karen L. Daniel
-
Karen L. Daniel，自2000年以来，她一直担任Black & Veatch公司的部门总裁兼首席财务官，一家专门从事基础设施建设领域的能源、水和信息的全球领先的工程、建筑和咨询公司。
Karen L. Daniel,graduated from Northwest Missouri State University and received her master's degree in accounting from the University of Missouri-Kansas City. She spent 11 years with the certified public accounting firm of Peat Marwick (KPMG), rising to Senior Audit Manager. She retired from Black & Veatch in July 2018 as Chief Financial Officer (CFO) and Executive Director. Ms. Daniel joined Black & Veatch in 1992 with the internal audit group, was named Chief Financial Officer in 1999 and joined the Black & Veatch Board of Directors in 2006. In her role as CFO, she was responsible for developing and executing business strategies, and as President of Black & Veatch's Global Finance & Technology Solutions Division, led the global finance and IT organizations. Ms. Daniel serves on numerous public and philanthropic boards: Snap-on, Inc., Giant Eagle, and Kansas City Campus for Animal Care, KC Royals Foundation, Ewing Marion Kauffman Foundation, and the 2017 Chair of the KC Chamber Board of Directors, completing her final term in November 2018. In 2023, Ms. Daniel was appointed President of the Board of Directors for KC2026 which is responsible to deliver World Cup matches and associated activities to the KC region. Ms. Daniel also served as Vice-Chair of former President Obama's Advisory Council on Doing Business in Africa. - Karen L. Daniel，自2000年以来，她一直担任Black & Veatch公司的部门总裁兼首席财务官，一家专门从事基础设施建设领域的能源、水和信息的全球领先的工程、建筑和咨询公司。
- Karen L. Daniel,graduated from Northwest Missouri State University and received her master's degree in accounting from the University of Missouri-Kansas City. She spent 11 years with the certified public accounting firm of Peat Marwick (KPMG), rising to Senior Audit Manager. She retired from Black & Veatch in July 2018 as Chief Financial Officer (CFO) and Executive Director. Ms. Daniel joined Black & Veatch in 1992 with the internal audit group, was named Chief Financial Officer in 1999 and joined the Black & Veatch Board of Directors in 2006. In her role as CFO, she was responsible for developing and executing business strategies, and as President of Black & Veatch's Global Finance & Technology Solutions Division, led the global finance and IT organizations. Ms. Daniel serves on numerous public and philanthropic boards: Snap-on, Inc., Giant Eagle, and Kansas City Campus for Animal Care, KC Royals Foundation, Ewing Marion Kauffman Foundation, and the 2017 Chair of the KC Chamber Board of Directors, completing her final term in November 2018. In 2023, Ms. Daniel was appointed President of the Board of Directors for KC2026 which is responsible to deliver World Cup matches and associated activities to the KC region. Ms. Daniel also served as Vice-Chair of former President Obama's Advisory Council on Doing Business in Africa.
高管简历
中英对照 | 中文 | 英文- Lee Shapiro
Lee Shapiro， 他一直担任7wire Ventures公司（他共同创立的一家风险投资公司，从事创新想法和企业家的投资，主要是消费主导型医疗保健和教育技术等领域）的管理合伙人（2013年以来）。此前，他曾担任Allscripts Healthcare Solutions, Inc.（一个上市医疗卫生信息技术公司，Allscripts）总裁（2002年至2012年12月），也曾担任Allscripts公司的首席执行官顾问（2013年1月至2013年6月）。加入Allscripts公司之前，他曾担任Douglas Elliman-Beitler公司（商业办公管理和开发公司）的首席运营官（从1998年到2000年），在那里他曾领导所有美国商业活动，职业生涯中，他也担任SES Properties, Inc.的总裁、City Financial Bancorp的副董事长，并在Barack、Ferrazzano、Kirschbaum、Perlman & Nagelberg从事商法实践。除了任职一些私营公司的董事会，他目前任职于Medidata Solutions, Inc. （一个公开交易的全球生命科学云解决方案的供应商，在那里他担任审计委员会和提名和公司治理委员会的成员）、 Aptus Health, Inc（Merck & Co., Inc.的全资子公司，专业医学团队 的医疗信息、药物样品和移动决策支持工具的网络资源的最大供应商之一，原为Physicians Interactive Holdings, LLC，"PIH"，在那里他主管审计委员会，并担任薪酬委员会的成员）、the American Heart Association的董事会。2009年至2010年，他也曾被任命到伊利诺伊州的经济复苏委员会（the Economic Recovery Commission of the State of Illinois）。他获得The University of Chicago Law School的法学博士学位。
Lee Shapiro, one of our directors, is the Chief Financial Officer of Livongo and Managing Partner at 7Wire, an investment firm he co-founded over a decade ago. Previously, he was President of Allscripts from 2002 to 2012. Mr. Shapiro's responsibilities included the company's strategy, international operations, business development and partnerships, legal, government relations, health plan initiatives and business activities in the areas of analytics and information services. At times during his tenure at Allscripts, he served as the company's Chief Operating Officer leveraging his unique grasp of the business operations across the spectrum of development, sales, marketing, services and support. Mr. Shapiro previously served on the board of directors of Livongo, where he chaired the audit committee and served as a member of the compensation committee. He also was a member of the executive leadership team, with a focus on strategy and business development. Mr. Shapiro served on the board of directors of Medidata Nasdaq: MDSO, where he served on the audit committee and nominating and governance committee, from 2011 until its sale to Dassault in 2019. Mr. Shapiro also served on the board of Tivity (Nasdaq: TVTY), where he chaired the audit committee and served on the compensation committee, from 2015 until May 2020. He also currently serves on the board and committees of various 7Wire portfolio companies. Since 2016 Mr. Shapiro has been a member of the National Board of Directors of the American Heart Association, where he chairs the audit committee and serves on the business operations committee. Mr. Shapiro practiced commercial law at Barack, Ferrazzano, Kirschbaum, Perlman and Nagelberg, a prominent Chicago law firm. Mr. Shapiro holds a JD degree from The University of Chicago Law School and a BS in Accounting from the University of Illinois.- Lee Shapiro， 他一直担任7wire Ventures公司（他共同创立的一家风险投资公司，从事创新想法和企业家的投资，主要是消费主导型医疗保健和教育技术等领域）的管理合伙人（2013年以来）。此前，他曾担任Allscripts Healthcare Solutions, Inc.（一个上市医疗卫生信息技术公司，Allscripts）总裁（2002年至2012年12月），也曾担任Allscripts公司的首席执行官顾问（2013年1月至2013年6月）。加入Allscripts公司之前，他曾担任Douglas Elliman-Beitler公司（商业办公管理和开发公司）的首席运营官（从1998年到2000年），在那里他曾领导所有美国商业活动，职业生涯中，他也担任SES Properties, Inc.的总裁、City Financial Bancorp的副董事长，并在Barack、Ferrazzano、Kirschbaum、Perlman & Nagelberg从事商法实践。除了任职一些私营公司的董事会，他目前任职于Medidata Solutions, Inc. （一个公开交易的全球生命科学云解决方案的供应商，在那里他担任审计委员会和提名和公司治理委员会的成员）、 Aptus Health, Inc（Merck & Co., Inc.的全资子公司，专业医学团队 的医疗信息、药物样品和移动决策支持工具的网络资源的最大供应商之一，原为Physicians Interactive Holdings, LLC，"PIH"，在那里他主管审计委员会，并担任薪酬委员会的成员）、the American Heart Association的董事会。2009年至2010年，他也曾被任命到伊利诺伊州的经济复苏委员会（the Economic Recovery Commission of the State of Illinois）。他获得The University of Chicago Law School的法学博士学位。
- Lee Shapiro, one of our directors, is the Chief Financial Officer of Livongo and Managing Partner at 7Wire, an investment firm he co-founded over a decade ago. Previously, he was President of Allscripts from 2002 to 2012. Mr. Shapiro's responsibilities included the company's strategy, international operations, business development and partnerships, legal, government relations, health plan initiatives and business activities in the areas of analytics and information services. At times during his tenure at Allscripts, he served as the company's Chief Operating Officer leveraging his unique grasp of the business operations across the spectrum of development, sales, marketing, services and support. Mr. Shapiro previously served on the board of directors of Livongo, where he chaired the audit committee and served as a member of the compensation committee. He also was a member of the executive leadership team, with a focus on strategy and business development. Mr. Shapiro served on the board of directors of Medidata Nasdaq: MDSO, where he served on the audit committee and nominating and governance committee, from 2011 until its sale to Dassault in 2019. Mr. Shapiro also served on the board of Tivity (Nasdaq: TVTY), where he chaired the audit committee and served on the compensation committee, from 2015 until May 2020. He also currently serves on the board and committees of various 7Wire portfolio companies. Since 2016 Mr. Shapiro has been a member of the National Board of Directors of the American Heart Association, where he chairs the audit committee and serves on the business operations committee. Mr. Shapiro practiced commercial law at Barack, Ferrazzano, Kirschbaum, Perlman and Nagelberg, a prominent Chicago law firm. Mr. Shapiro holds a JD degree from The University of Chicago Law School and a BS in Accounting from the University of Illinois.
- Jennifer Schneider
- 暂无中文简介
Jennifer Schneider has served as our President since December 2018 and previously served as our Chief Medical Officer from September 2015 to December 2018. Prior to joining us, she served in various executive roles at Castlight Health, Inc., a healthcare care navigation company, from May 2010 to September 2015 most recently as Chief Medical Officer from November 2014 to September 2015 and as Vice President, Strategic Analytics from September 2013 to October 2014. Dr. Schneider holds a B.A. in Biology from College of the Holy Cross, an M.S. in Health Services Research from Stanford University and an M.D. from Johns Hopkins University. - 暂无中文简介
- Jennifer Schneider has served as our President since December 2018 and previously served as our Chief Medical Officer from September 2015 to December 2018. Prior to joining us, she served in various executive roles at Castlight Health, Inc., a healthcare care navigation company, from May 2010 to September 2015 most recently as Chief Medical Officer from November 2014 to September 2015 and as Vice President, Strategic Analytics from September 2013 to October 2014. Dr. Schneider holds a B.A. in Biology from College of the Holy Cross, an M.S. in Health Services Research from Stanford University and an M.D. from Johns Hopkins University.
- Zane Burke
Zane Burke自2019年2月起担任我们的首席执行官，自2019年4月起担任我们的董事之一。在加入我们之前，他曾在塞纳公司担任多个执行职位，该公司是一家健康信息技术解决方案、服务、设备和硬件提供商，1996年9月至2018年11月，最近担任总裁（2013年9月至2018年11月）和执行Vice President-客户组织（2011年7月至2013年9月）。Burke先生拥有堪萨斯州立大学（Kansas State University）会计学学士学位和会计学硕士学位。他是一名注册会计师，但不再持有有效执照。此外，伯克先生还担任杜鲁门医学中心、梦百合信息管理执行学院和堪萨斯州立大学商学院咨询委员会的董事。
Zane Burke has served as our Chief Executive Officer since February 2019 and as one of our directors since April 2019. Prior to joining us, he served in various executive roles at Cerner Corporation, a provider of health information technology solutions, services, devices and hardware, from September 1996 to November 2018 most recently as President from September 2013 until November 2018 and Executive Vice President - Client Organization from July 2011 to September 2013. Mr. Burke holds a B.S. in Accounting and a Masters of Accountancy from Kansas State University. He is a certified public accountant, but no longer keeps an active license. Additionally, Mr. Burke serves on the Board of the Truman Medical Center, the Board of the College of Healthcare Information Management Executives and the Kansas State University School of Business Advisory Council.- Zane Burke自2019年2月起担任我们的首席执行官，自2019年4月起担任我们的董事之一。在加入我们之前，他曾在塞纳公司担任多个执行职位，该公司是一家健康信息技术解决方案、服务、设备和硬件提供商，1996年9月至2018年11月，最近担任总裁（2013年9月至2018年11月）和执行Vice President-客户组织（2011年7月至2013年9月）。Burke先生拥有堪萨斯州立大学（Kansas State University）会计学学士学位和会计学硕士学位。他是一名注册会计师，但不再持有有效执照。此外，伯克先生还担任杜鲁门医学中心、梦百合信息管理执行学院和堪萨斯州立大学商学院咨询委员会的董事。
- Zane Burke has served as our Chief Executive Officer since February 2019 and as one of our directors since April 2019. Prior to joining us, he served in various executive roles at Cerner Corporation, a provider of health information technology solutions, services, devices and hardware, from September 1996 to November 2018 most recently as President from September 2013 until November 2018 and Executive Vice President - Client Organization from July 2011 to September 2013. Mr. Burke holds a B.S. in Accounting and a Masters of Accountancy from Kansas State University. He is a certified public accountant, but no longer keeps an active license. Additionally, Mr. Burke serves on the Board of the Truman Medical Center, the Board of the College of Healthcare Information Management Executives and the Kansas State University School of Business Advisory Council.
- James Pursley
James Pursley自2014年4月以来一直担任我们的首席商务官。加入我们之前，他曾担任Care Innovations公司的多种执行职务（从2011年1月到2014年4月），最近担任Vice President、销售与市场营销（从2012年8月到2014年4月）。Pursley先生拥有宾夕法尼亚州立大学（Pennsylvania State University）管理科学与信息系统学士学位和西北大学凯洛格管理学院（Kellogg School of Management at Northwestern University）工商管理硕士学位。
James Pursley has served as our Chief Commercial Officer since April 2014. Prior to joining us, he served in various executive roles at Care Innovations from January 2011 to April 2014 most recently as Vice President, Sales and Marketing from August 2012 to April 2014. Mr. Pursley holds a B.S. in Management Sciences and Information Systems from Pennsylvania State University and an M.B.A. from the Kellogg School of Management at Northwestern University.- James Pursley自2014年4月以来一直担任我们的首席商务官。加入我们之前，他曾担任Care Innovations公司的多种执行职务（从2011年1月到2014年4月），最近担任Vice President、销售与市场营销（从2012年8月到2014年4月）。Pursley先生拥有宾夕法尼亚州立大学（Pennsylvania State University）管理科学与信息系统学士学位和西北大学凯洛格管理学院（Kellogg School of Management at Northwestern University）工商管理硕士学位。
- James Pursley has served as our Chief Commercial Officer since April 2014. Prior to joining us, he served in various executive roles at Care Innovations from January 2011 to April 2014 most recently as Vice President, Sales and Marketing from August 2012 to April 2014. Mr. Pursley holds a B.S. in Management Sciences and Information Systems from Pennsylvania State University and an M.B.A. from the Kellogg School of Management at Northwestern University.
- Jennifer Schneider
Jennifer Schneider,自2018年起担任Livongo总裁，负责产品、数据科学、工程、市场营销、临床运营和增长战略。Schneider博士着有《解码健康信号：硅谷面向健康新时代的消费者至上方法》一书，该书为当今行业面临的慢性病问题的深度提供了指南，并探讨了企业如何利用大数据分析和人工智能为患有慢性病的人重塑护理服务。Schneider博士最近入选了Modern Healthcare的顶级临床高管名单。在加入Livongo之前，Schneider博士曾于2010年至2015年在Castlight Health担任多个关键领导职务，最近一次担任首席医疗官。Schneider博士还曾在2005年至2006年期间担任斯坦福大学健康结果研究人员和首席住院医师的领导职务，她曾在斯坦福大学、VA Palo Alto医疗保健系统和Kaiser Permanente担任主治医师。Schneider博士拥有圣十字学院本科学位-1997年约翰霍普金斯医学院医学博士学位-2002年和斯坦福大学健康服务研究理学硕士学位-2010年Schneider博士完成了她在斯坦福大学医院的内科住院医师实习。
Jennifer Schneider, Director, has been the President of Livongo since 2018 where she is responsible for product, data science, engineering, marketing, clinical operations, and growth strategy. Dr. Schneider previously served as the company's Chief Medical Officer from 2015 to 2018 where she led the company's strategic clinical product vision, data science, clinical trials, and the organization's certified diabetes educators and coaches. Dr. Schneider is the author of Decoding Health Signals: Silicon Valley's Consumer-First Approach to a New Era of Health, which offers a guide to the depth of the chronic conditions problem facing the industry today and explores how companies are using big data analytics and artificial intelligence to reinvent care delivery for people with chronic conditions. Dr. Schneider was recently named to Modern Healthcare's List of Top Clinical Executives.Prior to Livongo, Dr. Schneider held several key leadership roles at Castlight Health from 2010 to 2015 most recently as Chief Medical Officer. Dr. Schneider also has held leadership roles as a health outcomes researcher and Chief Resident at Stanford University from 2005 to 2006 and she has practiced medicine as an attending physician at Stanford University, the VA Palo Alto Health Care System, and Kaiser Permanente. Dr. Schneider has an undergraduate degree from the College of the Holy Cross -1997 a Doctor of Medicine degree from Johns Hopkins School of Medicine -2002 and a Master of Science degree in Health Services Research from Stanford University -2010 Dr. Schneider completed her internal medicine residency at Stanford University Hospital.- Jennifer Schneider,自2018年起担任Livongo总裁，负责产品、数据科学、工程、市场营销、临床运营和增长战略。Schneider博士着有《解码健康信号：硅谷面向健康新时代的消费者至上方法》一书，该书为当今行业面临的慢性病问题的深度提供了指南，并探讨了企业如何利用大数据分析和人工智能为患有慢性病的人重塑护理服务。Schneider博士最近入选了Modern Healthcare的顶级临床高管名单。在加入Livongo之前，Schneider博士曾于2010年至2015年在Castlight Health担任多个关键领导职务，最近一次担任首席医疗官。Schneider博士还曾在2005年至2006年期间担任斯坦福大学健康结果研究人员和首席住院医师的领导职务，她曾在斯坦福大学、VA Palo Alto医疗保健系统和Kaiser Permanente担任主治医师。Schneider博士拥有圣十字学院本科学位-1997年约翰霍普金斯医学院医学博士学位-2002年和斯坦福大学健康服务研究理学硕士学位-2010年Schneider博士完成了她在斯坦福大学医院的内科住院医师实习。
- Jennifer Schneider, Director, has been the President of Livongo since 2018 where she is responsible for product, data science, engineering, marketing, clinical operations, and growth strategy. Dr. Schneider previously served as the company's Chief Medical Officer from 2015 to 2018 where she led the company's strategic clinical product vision, data science, clinical trials, and the organization's certified diabetes educators and coaches. Dr. Schneider is the author of Decoding Health Signals: Silicon Valley's Consumer-First Approach to a New Era of Health, which offers a guide to the depth of the chronic conditions problem facing the industry today and explores how companies are using big data analytics and artificial intelligence to reinvent care delivery for people with chronic conditions. Dr. Schneider was recently named to Modern Healthcare's List of Top Clinical Executives.Prior to Livongo, Dr. Schneider held several key leadership roles at Castlight Health from 2010 to 2015 most recently as Chief Medical Officer. Dr. Schneider also has held leadership roles as a health outcomes researcher and Chief Resident at Stanford University from 2005 to 2006 and she has practiced medicine as an attending physician at Stanford University, the VA Palo Alto Health Care System, and Kaiser Permanente. Dr. Schneider has an undergraduate degree from the College of the Holy Cross -1997 a Doctor of Medicine degree from Johns Hopkins School of Medicine -2002 and a Master of Science degree in Health Services Research from Stanford University -2010 Dr. Schneider completed her internal medicine residency at Stanford University Hospital.
- Glen E. Tullman
Glen E. Tullman，1997年8月加入，担任首席执行官，领导本公司进入医疗保健信息行业。1999年5月，他当选为本公司董事。加入Allscripts之前，1994年10月至1997年7月，他担任Enterprise Systems的首席执行官，这是一个医疗信息服务公司，为大型综合医疗保健网络提供资源管理解决方案。1983-1994，他在CCC Information Services担任过一些管理职务，其中包括总裁、首席运营官，这是财产与意外保险公司的信息系统提供商。他目前任职于Juvenile Diabetes Research Foundation的国际委员会。
Glen E. Tullman is a founder of the Company and has served as our Executive Chairman since February 2019 and previously served as our Chief Executive Officer from September 2014 to February 2019. Mr. Tullman has also served as one of our directors since August 2013. He co-founded 7Wire Ventures, an early-stage healthcare venture fund, and has served as a Managing Partner since January 2013. Previously, Mr. Tullman served as Chief Executive Officer and as a director of Allscripts Healthcare Solutions, Inc., a provider of electronic prescribing, practice management and electronic health record technology, from August 1997 to December 2012. He serves as a Director Emeritus to the International Board of the Juvenile Diabetes Research Foundation and on the board of directors of the American Diabetes Association. Mr. Tullman holds a B.A. in Economics from Bucknell University and an advanced degree in Social Anthropology from St. Antony’s College, University of Oxford.- Glen E. Tullman，1997年8月加入，担任首席执行官，领导本公司进入医疗保健信息行业。1999年5月，他当选为本公司董事。加入Allscripts之前，1994年10月至1997年7月，他担任Enterprise Systems的首席执行官，这是一个医疗信息服务公司，为大型综合医疗保健网络提供资源管理解决方案。1983-1994，他在CCC Information Services担任过一些管理职务，其中包括总裁、首席运营官，这是财产与意外保险公司的信息系统提供商。他目前任职于Juvenile Diabetes Research Foundation的国际委员会。
- Glen E. Tullman is a founder of the Company and has served as our Executive Chairman since February 2019 and previously served as our Chief Executive Officer from September 2014 to February 2019. Mr. Tullman has also served as one of our directors since August 2013. He co-founded 7Wire Ventures, an early-stage healthcare venture fund, and has served as a Managing Partner since January 2013. Previously, Mr. Tullman served as Chief Executive Officer and as a director of Allscripts Healthcare Solutions, Inc., a provider of electronic prescribing, practice management and electronic health record technology, from August 1997 to December 2012. He serves as a Director Emeritus to the International Board of the Juvenile Diabetes Research Foundation and on the board of directors of the American Diabetes Association. Mr. Tullman holds a B.A. in Economics from Bucknell University and an advanced degree in Social Anthropology from St. Antony’s College, University of Oxford.